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To the Editor: 
We found no published works reporting COVID-19 infection presenting as neutropenic fever in renal 
transplant adult patients. We report the first case. 
On March 18, 2020, a 33-year-old female presented to our hospital with chief complaint of dry cough 
and dyspnea for 5 days prior to admission that progressively gotten worse. She had fever (temperature 
of 38.3°C) and malaise. She had End Stage Renal Disease (ESRD) and had Living Unrelated Kidney 
Transplant in February of 2019. She travelled to Ghana for medical mission trip with layover in Paris on 
March 6th. Physical exam was remarkable for bilateral crackles in her lungs and labored respiration. 
Labs showed low white blood cell (absolute neutrophil count of 0.8 k/cumm). A 
nasopharyngeal/oropharyngeal swab specimen was obtained and sent for detection of COVID-19. Rapid 
flu A/B test and HIV-1/-2 Ab/HIV Ag QL were negative. CMV IgG EIA QN and EBV VCA IgM EIA were not 
checked during this admission. Computerized tomography scan of chest showed new patchy peripheral 
interstitial and airspace opacities with air bronchograms within both lungs. The PCR for COVID-19 came 
back positive (confirmed by COVID-19 GeneXpert detection) on March 19, 2020. The patient was 
initiated on Hydroxychloroquine 400 mg po twice a day for 1 day then 200 mg twice a day for total 
5 days. Given her immunosuppressed status with COVID-19 associated with neutropenic fever, she was 
given Cefepime for 5 days and Azithromycin for 3 days. Home medications were continued including 
Fluticasone and Salmeterol Diskus, Ferrous Gluconate, Malarone (Atovaquone and Proguanil), 
Montelukast, Tacrolimus, Acetaminophen, Albuterol HFA, Ondansetron and Cetirizine. The patient was 
not on ACE inhibitor due to the fact she had history of angioedema. She was given IVF in the form of 
Sodium Chloride 0.9% at 100 mL/hour. Her Mycophenolic acid was stopped when her COVID-19 test 
came back positive and her Tacrolimus dose was adjusted to achieve a level of 3-5 ng/mL. 
Her creatinine, WBCs, platelets and hemoglobin dropped during her hospitalization (Figure 1). The 
patient improved and was discharged home on March 24, 2020. She was placed on self-quarantine till 
April 17, 2020. The patient's symptoms resolved on April 30, 2020 with both clinical and laboratorial 
improvement. 
1 DISCUSSION 
The clinical spectrum of SARS-CoV-2 infection appears to be wide, encompassing asymptomatic 
infection, mild upper respiratory tract illness and severe viral pneumonia with respiratory failure and 
even death.1-5 Transplant patients are felt to be at higher risk as immunosuppression, underlying CKD 
and other co-morbidities are now recognized as significant factors that influence outcomes in patients 
with COVID 19 infection.4, 5 Most of those patients had fever and lymphopenia. Those patients had 
more rapid clinical progression and very high early mortality as compared with general population 
infected with COVID-19.5 
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Our patient had multiple comorbidities (immunosuppression, obesity, HTN and asthma), worsening 
symptoms and pneumonia upon presentation and despite that had a favorable outcome after 
treatment. Our case supports recent recommendations that immunosuppression be lowered but not 
discontinued. This is the first reported case of COVID-19 presenting with neutropenic fever. Other 
reasons cannot be ruled out, but we could not find another explanation and hope future studies and 
case series will pay attention to neutropenic fever in transplant patient with COVID-19. The kidney 
function improvement is either sign of good prognosis or might have protective effect against COVID-19 
and worth studying as well. 
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The graphs show drop in white blood count (WBC) and creatinine during the symptomatic active phase 
of COVID-19 infection in our patient. Note improvement at recovery of WBCs after treatment. Source: 
Cerner Electronic Medical Records, IUH Arnett Hospital, Lafayette, IN, United States 
 
